Longitudinal therapy monitoring of ALK-positive non-small cell lung cancer (copy number, cell-free DNA)
收藏NIAID Data Ecosystem2026-03-12 收录
下载链接：
https://www.omicsdi.org/dataset/ega/EGAS00001004276
下载链接
链接失效反馈官方服务：
资源简介：
Clinical courses of non-small cell lung cancer patients with ALK rearrangements (ALK+ NSCLC) vary widely. We analyzed 271 longitudinal plasma samples from 73 patients with advanced ALK+ NSCLC treated with ALK tyrosine kinase inhibitors by combined hybrid-capture-based targeted sequencing (average 4,100x coverage) for mutation analysis and shallow whole genome sequencing (0.5x coverage) for global copy number profiling from cfDNA.EGA study EGAS00001004276
创建时间：
2020-11-16
